{"id":"W1989556851","doi":"10.1517/13543770903059125","title":"The search for new COX-2 inhibitors: a review of 2002 – 2008 patents","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Fundação de Amparo à Pesquisa do Estado de Minas Gerais; Merck Canada; Conselho Nacional de Desenvolvimento Científico e Tecnológico","keywords":"Naproxen; Valdecoxib; Celecoxib; Medicine; Ibuprofen; Pharmacology; Inflammation; Cyclooxygenase; Nabumetone; Aspirin; Etoricoxib; Nonsteroidal; Chemistry; Enzyme; Rofecoxib; Internal medicine; Biochemistry","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00108579,0.0007551081,0.00254317,0.0002089241,0.0002097867,0.00002620613,0.0004835394,0.0004677392,0.0001152097],"category_scores_gemma":[0.0001561438,0.0004290496,0.001274994,0.0004043567,0.0001064996,0.00004409764,0.00005681451,0.0005581232,0.0001886722],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002214402,"about_ca_system_score_gemma":0.0008121607,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001756422,"about_ca_topic_score_gemma":3.062051e-7,"domain_scores_codex":[0.9957235,0.0004961372,0.001403973,0.0006257436,0.001018595,0.0007320367],"domain_scores_gemma":[0.9970599,0.0005453213,0.0006808031,0.001062951,0.0002623999,0.0003886419],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001287736,0.0001931819,0.000004074918,0.02749236,0.0003495834,0.000007071746,0.00007274914,3.842401e-8,0.000004441027,0.00003976029,0.06532793,0.90638],"study_design_scores_gemma":[0.001212083,0.0009546479,0.00001188642,0.1849595,0.0001578083,0.00003387637,0.000007519921,0.000005316263,0.00009456919,0.00001150824,0.8122378,0.0003135121],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001249801,0.9903876,0.00003330669,0.0007756657,0.002745703,0.005725929,0.00005167639,0.00005904885,0.0002197848],"genre_scores_gemma":[0.000003466412,0.9938167,0.00005243629,0.002345138,0.001676704,0.0004858414,0.0003057053,0.000131774,0.001182262],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9060665,"threshold_uncertainty_score":0.9998161,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1324520550520304,"score_gpt":0.4087917491154659,"score_spread":0.2763396940634354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}